Continuum Advisory’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
BBA
Continuum Advisory's PRAX Position: Q3 2026 in Review
Continuum Advisory opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 4 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #1781 among its holdings.
339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.
- Continuum Advisory held 4 shares of Praxis Precision Medicines worth $1.16K as of Q3 2026.
- Praxis Precision Medicines was a new Continuum Advisory position in Q3 2026.
- Praxis Precision Medicines made up ﹤0.01% of Continuum Advisory's portfolio in Q3 2026, its #1781 holding.
- 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.
Based on Continuum Advisory's 13F filing for Q3 2026, filed 13 Nov 2026.